Bosh sahifaRV7 • FRA
add
Halozyme Therapeutics, Inc.
Yopilish kursi
53,06 €
Kunlik diapazon
53,18 € - 53,18 €
Yillik diapazon
35,90 € - 60,68 €
Bozor kapitalizatsiyasi
7,52 mlrd USD
Oʻrtacha hajm
196,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 298,01 mln | 29,55% |
Joriy xarajat | 60,01 mln | 8,38% |
Sof foyda | 137,01 mln | 60,46% |
Sof foyda marjasi | 45,98 | 23,87% |
Har bir ulushga tushum | 1,26 | 53,66% |
EBITDA | 194,52 mln | 61,52% |
Amaldagi soliq stavkasi | 23,12% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 596,07 mln | 77,40% |
Jami aktivlari | 2,06 mlrd | 19,05% |
Jami passivlari | 1,70 mlrd | 3,04% |
Umumiy kapital | 363,82 mln | — |
Tarqatilgan aksiyalar | 123,15 mln | — |
Narxi/balansdagi bahosi | 17,99 | — |
Aktivlardan daromad | 20,99% | — |
Kapitaldan daromad | 22,57% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 137,01 mln | 60,46% |
Operatsiyalardan naqd pul | 178,47 mln | 74,36% |
Sarmoyadan naqd pul | 29,48 mln | 455,57% |
Moliyadan naqd pul | -246,42 mln | 1,40% |
Naqd pulning sof oʻzgarishi | -38,47 mln | 75,32% |
Boʻsh pul | 132,16 mln | 73,85% |
Haqida
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Tashkil etilgan
1998
Sayt
Xodimlar soni
350
